X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (183) 183
heart failure (176) 176
cardiac & cardiovascular systems (151) 151
index medicus (144) 144
male (125) 125
female (123) 123
aged (110) 110
cardiovascular (108) 108
middle aged (96) 96
mortality (94) 94
abridged index medicus (73) 73
cardiac patients (71) 71
heart failure - therapy (65) 65
article (62) 62
exercise (58) 58
hospitalization (51) 51
treatment outcome (50) 50
heart failure - physiopathology (44) 44
risk factors (40) 40
quality of life (39) 39
heart failure - mortality (38) 38
analysis (36) 36
clinical trials (36) 36
heart attacks (36) 36
outcomes (36) 36
patients (30) 30
drug therapy (29) 29
care and treatment (28) 28
exercise therapy (28) 28
prognosis (27) 27
follow-up studies (25) 25
heart (25) 25
heart failure - diagnosis (25) 25
medical research (25) 25
risk (24) 24
adult (23) 23
medical colleges (23) 23
medicine, general & internal (23) 23
patient outcomes (23) 23
studies (23) 23
united states - epidemiology (23) 23
management (22) 22
medicine, experimental (22) 22
randomized controlled-trial (22) 22
retrospective studies (22) 22
aged, 80 and over (21) 21
cardiology (21) 21
disease management (21) 21
heart failure - rehabilitation (21) 21
prospective studies (21) 21
therapy (21) 21
cardiovascular disease (20) 20
heart failure - complications (20) 20
heart failure - economics (20) 20
quality-of-life (20) 20
united states (20) 20
association (18) 18
chronic disease (18) 18
comorbidity (18) 18
hf-action (18) 18
research (18) 18
stroke volume (18) 18
time factors (18) 18
biomarkers (17) 17
cardiomyopathy (17) 17
heart diseases (17) 17
morbidity (17) 17
proportional hazards models (17) 17
care (16) 16
disease (16) 16
older people (16) 16
myocardial-infarction (15) 15
risk assessment (15) 15
trial (15) 15
ejection (14) 14
health aspects (14) 14
heart failure - drug therapy (14) 14
heart failure - epidemiology (14) 14
internal medicine (14) 14
survival analysis (14) 14
clinical outcomes (13) 13
confidence intervals (13) 13
exercise therapy - methods (13) 13
heart failure - blood (13) 13
hospitalization - statistics & numerical data (13) 13
program (13) 13
training (13) 13
exercise tolerance (12) 12
health status (12) 12
heart failure - psychology (12) 12
hospitals (12) 12
medicare (12) 12
readmission (12) 12
severity of illness index (12) 12
biomarkers - blood (11) 11
cardiology and cardiovascular medicine (11) 11
cohort studies (11) 11
coronary-artery-disease (11) 11
intervention (11) 11
natriuretic peptide, brain - blood (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 09/2019, Volume 171, Issue 6, pp. 430 - 430
Journal Article
Circulation, ISSN 0009-7322, 09/2009, Volume 120, Issue 12, pp. 1141 - 1163
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2017, Volume 70, Issue 20, pp. 2501 - 2503
Atrial fibrillation (AF) is the most common arrhythmia in patients with heart failure (HF) with reduced ejection fraction (HFrEF). The point estimates of the... 
heart failure | atrial fibrillation | anticoagulation | CARDIAC & CARDIOVASCULAR SYSTEMS | DEVICE | RISK | RHYTHM | CONGESTIVE-HEART-FAILURE | ATRIAL-FIBRILLATION | Studies | Heart failure | Heart rate | Cardiac arrhythmia | Sinuses | Cardiomyopathy | Mortality | Family medical history | Beta blockers | Patients | Clinical outcomes
Journal Article
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 20 - 33
In this trial, vorapaxar, a protease-activated–receptor 1 antagonist that inhibits thrombin-induced platelet activation, was not effective in reducing the... 
MEDICINE, GENERAL & INTERNAL | PLACEBO | GLYCOPROTEIN IIB/IIIA INHIBITORS | CLOPIDOGREL | TASK-FORCE | SAFETY | DOUBLE-BLIND | ANTIPLATELET THERAPY | Follow-Up Studies | Angioplasty | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Combined Modality Therapy | Lactones - adverse effects | Lactones - therapeutic use | Acute Coronary Syndrome - drug therapy | Intracranial Hemorrhages - chemically induced | Coronary Artery Bypass | Acute Coronary Syndrome - therapy | Aged | Hemorrhage - chemically induced | Antagonists (Biochemistry) | Drugs | Dose-response relationship (Biochemistry) | Dosage and administration | Product/Service Evaluations | Drug therapy | Coronary heart disease | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Cardiovascular disease | Hemorrhage | Bleeding | Investigations | Manuscripts | Ischemia | Blood platelets | Acute coronary syndromes | Research centers | Malalties cardiovasculars | Bypass cardiopulmonar | Medicaments | Bypass cardiopulmonary | Plaquetes sanguínies | Cardiovascular diseases | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article